BRGX
BioRegenx, Inc.
Price Chart
Latest Quote
$0.01
+0.00 (+0.00%)
Current Price
| Previous Close | $0.01 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 26,000 |
Stock Information
| Shares Outstanding | 971.58M |
| Total Debt | $2.17M |
| Cash Equivalents | $46K |
| Revenue | $1.77M |
| Net Income | $-1.30M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $8.99M |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $11.11M |
| Sales | $1.77M |
| Income | $-1.30M |
| Book/sh | $-0.01 |
| Cash/sh | $0.00 |
| Employees | 6 |
Financial Ratios
| Quick Ratio | 0.02 |
| Current Ratio | 0.05 |
Returns & Margins
| ROA | -57.36% |
| Gross Margin | 81.90% |
| Operating Margin | -11.68% |
| Profit Margin | -73.81% |
Ownership
| Insider Ownership | 74.52% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 5.09 |
| P/B | -1.85 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.01 |
| SMA200 | $0.01 |
| RSI | 61.38 |
| ATR | 0.0005 |
| Shares Float | 258.13M |
| Volatility | -2.87 |
Performance History
| Week | +13.08% |
| Month | +2.78% |
| Quarter | -14.35% |
| 6 Months | -28.85% |
| YTD | -28.29% |
| Year | -17.41% |
| 3 Years | -84.58% |
| 5 Years | -89.49% |
| 10 Years | -7.50% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-04 | $0.01 | 0 |
| 2026-06-03 | $0.01 | 0 |
| 2026-06-02 | $0.01 | 48,000 |
| 2026-06-01 | $0.01 | 0 |
| 2026-05-29 | $0.01 | 0 |
| 2026-05-28 | $0.01 | 239,734 |
| 2026-05-27 | $0.01 | 70,000 |
| 2026-05-26 | $0.01 | 0 |
| 2026-05-22 | $0.01 | 4,902 |
| 2026-05-21 | $0.01 | 0 |
| 2026-05-20 | $0.01 | 0 |
| 2026-05-19 | $0.01 | 50,000 |
| 2026-05-18 | $0.01 | 266 |
| 2026-05-15 | $0.01 | 0 |
| 2026-05-14 | $0.01 | 0 |
| 2026-05-13 | $0.01 | 101 |
| 2026-05-12 | $0.01 | 0 |
| 2026-05-11 | $0.01 | 0 |
| 2026-05-08 | $0.01 | 37,005 |
| 2026-05-07 | $0.01 | 801 |
| 2026-05-06 | $0.01 | 60,000 |
| 2026-05-05 | $0.01 | 68,397 |
About BioRegenx, Inc.
BioRegenx, Inc. engages in the research, development, and commercialization of dietary supplements, medical devices, software, and contactless diagnostic technologies in the United States and internationally. The company offers DocSun AI engine, which integrates with a ballistocardiograph that detects an individual's heartbeat; TruScan.AI mobile app for additional health indications; VitalWellness app for DNA and epigenetics platform; and Endocalyx Pro, a dietary supplement targeting microvascular capillary health. It also provides MyBodyRx, a supplement; GlycoCheck software and medical devices; hydrogen water products and health and wellness devices, such as pulsed electro-magnetic field devices; StimaWELL and ReLounge electronic muscle stimulation therapy devices; and Findit.com, a social media content management platform. The company sells its products through a direct selling channel to health professionals and research organizations. BioRegenx, Inc. is headquartered in Chattanooga, Tennessee.
đ° Latest News
No news articles available at the moment. Check back later for updates on BRGX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $646,530 | $1,095,213 | $0 | $554 |
| Cost Of Revenue | $681,685 | $1,099,987 | $0 | $554 |
| Total Revenue | $2,340,106 | $3,411,415 | $42,159 | $198,584 |
| Operating Revenue | $2,601,839 | $3,687,945 | $42,159 | $198,584 |
| Expenses | ||||
| Interest Expense | $290,662 | $191,248 | $0 | - |
| Total Expenses | $8,890,840 | $6,820,249 | $120,467 | $363,702 |
| Other Income Expense | $-16,212,621 | $-453,232 | - | $68,245 |
| Net Non Operating Interest Income Expense | $-290,662 | $-191,248 | $0 | - |
| Interest Expense Non Operating | $290,662 | $191,248 | $0 | - |
| Operating Expense | $8,209,155 | $5,720,262 | $120,467 | $363,148 |
| Selling And Marketing Expense | $173,928 | $490,816 | $6,043 | $7,383 |
| General And Administrative Expense | $5,851,190 | $5,229,446 | $55,575 | $147,696 |
| Other Operating Expenses | - | $18,795 | $52,917 | $203,620 |
| Other Non Operating Income Expenses | - | - | - | $68,245 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-23,054,017 | $-3,600,082 | $-78,308 | $-96,873 |
| Net Interest Income | $-290,662 | $-191,248 | $0 | - |
| Normalized Income | $-6,841,396 | $-3,600,082 | $-78,308 | $-96,873 |
| Net Income From Continuing And Discontinued Operation | $-23,054,017 | $-3,600,082 | $-78,308 | $-96,873 |
| Total Operating Income As Reported | $-22,763,355 | $-3,408,834 | $-78,308 | $-165,118 |
| Net Income Common Stockholders | $-23,054,017 | $-3,600,082 | $-78,308 | $-96,873 |
| Net Income | $-23,054,017 | $-3,600,082 | $-78,308 | $-96,873 |
| Net Income Including Noncontrolling Interests | $-23,054,017 | $-3,600,082 | $-78,308 | $-96,873 |
| Net Income Continuous Operations | $-23,054,017 | $-3,600,082 | $-78,308 | $-96,873 |
| Pretax Income | $-23,054,017 | $-3,600,082 | $-78,308 | $-96,873 |
| Special Income Charges | $-16,212,621 | $0 | $0 | $0 |
| Operating Income | $-6,550,734 | $-3,408,834 | $-78,308 | $-165,118 |
| Depreciation Amortization Depletion Income Statement | $2,184,037 | $0 | $5,932 | $4,449 |
| Depreciation And Amortization In Income Statement | $2,184,037 | $0 | $5,932 | $4,449 |
| Amortization Of Intangibles Income Statement | $2,184,037 | $0 | $5,932 | $4,449 |
| Gross Profit | $1,658,421 | $2,311,428 | $42,159 | $198,030 |
| Per Share | ||||
| Diluted EPS | $-0.02 | $-0.01 | $-0.00 | $-0.00 |
| Basic EPS | $-0.02 | $-0.01 | $-0.00 | $-0.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-4,331,542 | $-3,404,060 | $-72,376 | $-160,669 |
| Total Unusual Items | $-16,212,621 | $0 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $-16,212,621 | $0 | $0 | $0 |
| Reconciled Depreciation | $2,219,192 | $4,774 | $5,932 | $4,449 |
| EBITDA (Bullshit earnings) | $-20,544,163 | $-3,404,060 | $-72,376 | $-160,669 |
| EBIT | $-22,763,355 | $-3,408,834 | $-78,308 | $-165,118 |
| Diluted Average Shares | $939,510,471 | $639,780,272 | $269,745,006 | $269,745,006 |
| Basic Average Shares | $939,510,471 | $639,780,272 | $269,745,006 | $269,745,006 |
| Diluted NI Availto Com Stockholders | $-23,054,017 | $-3,600,082 | $-78,308 | $-96,873 |
| Write Off | $16,212,621 | $0 | - | $0 |
| Amortization | $2,184,037 | $0 | $5,932 | $4,449 |
| Selling General And Administration | $6,025,118 | $5,720,262 | $61,618 | $155,079 |
| Other Gand A | $5,851,190 | $5,229,446 | $55,575 | $147,696 |
| Tax Provision | - | $0 | $0 | $0 |
| Other Special Charges | - | $453,232 | - | - |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-3,379,259 | $-2,120,790 | $-239,015 | $-127,638 |
| Total Assets | $508,535 | $865,750 | $59,149 | $127,762 |
| Total Non Current Assets | $200,739 | $213,086 | $58,473 | $103,404 |
| Goodwill And Other Intangible Assets | $0 | $49,363 | $37,473 | $43,404 |
| Current Assets | $307,796 | $652,664 | $676 | $24,358 |
| Other Current Assets | $118,143 | $142,685 | - | - |
| Prepaid Assets | $5,163 | $62,467 | - | - |
| Inventory | $111,094 | $217,529 | - | - |
| Receivables | $14,992 | $104,581 | - | $0 |
| Accounts Receivable | $14,992 | $104,581 | - | $0 |
| Cash Cash Equivalents And Short Term Investments | $58,404 | $125,402 | $676 | $24,358 |
| Cash And Cash Equivalents | $58,404 | $125,402 | $676 | $24,358 |
| Other Non Current Assets | - | $150,000 | - | - |
| Other Intangible Assets | - | $31,540 | $37,473 | $43,404 |
| Cash Financial | - | $0 | $676 | $24,358 |
| Debt | ||||
| Net Debt | $2,105,860 | $1,363,494 | $240,294 | $175,642 |
| Total Debt | $2,164,264 | $1,488,896 | $240,970 | $200,000 |
| Long Term Debt And Capital Lease Obligation | $254,606 | $150,000 | $195,811 | $197,837 |
| Long Term Debt | $254,606 | $150,000 | $195,811 | $197,837 |
| Current Debt And Capital Lease Obligation | $1,909,658 | $1,338,896 | $45,159 | $2,163 |
| Current Debt | $1,909,658 | $1,338,896 | $45,159 | $2,163 |
| Other Current Borrowings | - | $225,370 | $4,189 | $2,163 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,887,794 | $2,937,177 | $260,691 | $211,996 |
| Total Non Current Liabilities Net Minority Interest | $254,606 | $150,000 | $195,811 | $197,837 |
| Current Liabilities | $3,633,188 | $2,787,177 | $64,880 | $14,159 |
| Current Deferred Liabilities | $197,027 | $354,203 | - | $0 |
| Current Notes Payable | $1,909,658 | $1,338,896 | $40,970 | $0 |
| Payables And Accrued Expenses | $1,526,503 | $1,094,078 | $19,721 | $11,996 |
| Interest Payable | $424,277 | $292,190 | - | - |
| Payables | $649,266 | $455,211 | - | - |
| Accounts Payable | $427,478 | $241,695 | - | - |
| Equity | ||||
| Common Stock Equity | $-3,379,263 | $-2,071,431 | $-211,442 | $-94,134 |
| Preferred Stock Equity | $4 | $4 | $9,900 | $9,900 |
| Total Equity Gross Minority Interest | $-3,379,259 | $-2,071,427 | $-201,542 | $-84,234 |
| Stockholders Equity | $-3,379,259 | $-2,071,427 | $-201,542 | $-84,234 |
| Gains Losses Not Affecting Retained Earnings | $2,034 | $-942 | - | - |
| Other Equity Adjustments | $2,034 | $-942 | - | - |
| Retained Earnings | $-35,571,995 | $-12,517,978 | $-2,917,700 | $-2,800,392 |
| Long Term Equity Investment | - | $100 | $21,000 | $60,000 |
| Other | ||||
| Ordinary Shares Number | $956,994,100 | $276,750,406 | $269,745,006 | $269,745,006 |
| Share Issued | $956,994,100 | $276,750,406 | $269,745,006 | $269,745,006 |
| Tangible Book Value | $-3,379,263 | $-2,120,794 | $-248,915 | $-137,538 |
| Invested Capital | $-1,214,999 | $-582,535 | $29,528 | $105,866 |
| Working Capital | $-3,325,392 | $-2,134,513 | $-64,204 | $10,199 |
| Total Capitalization | $-3,124,653 | $-1,921,427 | $-5,731 | $113,603 |
| Additional Paid In Capital | $30,965,084 | $9,676,656 | $2,436,513 | $2,436,513 |
| Capital Stock | $1,225,618 | $770,837 | $279,645 | $279,645 |
| Common Stock | $1,225,614 | $770,833 | $269,745 | $269,745 |
| Preferred Stock | $4 | $4 | $9,900 | $9,900 |
| Current Deferred Revenue | $197,027 | $354,203 | - | $0 |
| Current Accrued Expenses | $877,237 | $638,867 | - | - |
| Dueto Related Parties Current | $221,788 | $213,516 | - | - |
| Net PPE | $200,739 | $13,723 | - | - |
| Gross PPE | $200,739 | - | - | - |
| Machinery Furniture Equipment | $200,739 | - | - | - |
| Finished Goods | $111,094 | $217,529 | - | - |
| Investments And Advances | - | $100 | $21,000 | $60,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-513,538 | $-1,564,406 | $-64,652 | $-119,517 |
| Operating Activities | ||||
| Operating Cash Flow | $-324,148 | $-1,515,043 | $-64,652 | $-119,517 |
| Cash Flow From Continuing Operating Activities | $-324,148 | $-1,515,043 | $-64,652 | $-119,517 |
| Operating Gains Losses | $2,870,396 | $2,501,853 | - | $165,000 |
| Investing Activities | ||||
| Capital Expenditure | $-189,390 | $-49,363 | - | - |
| Investing Cash Flow | $-187,945 | $-199,363 | $0 | $0 |
| Cash Flow From Continuing Investing Activities | $-187,945 | $-199,363 | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $1,342,141 | - | - |
| Financing Cash Flow | $442,119 | $1,204,322 | $40,970 | $50,000 |
| Cash Flow From Continuing Financing Activities | $442,119 | $1,204,322 | $40,970 | $50,000 |
| Net Common Stock Issuance | $0 | $1,342,141 | - | - |
| Common Stock Issuance | $0 | $1,342,141 | - | - |
| Other | ||||
| Repayment Of Debt | $-48,240 | $-211,672 | $-700 | $0 |
| Issuance Of Debt | $490,359 | $73,853 | $41,670 | $50,000 |
| Interest Paid Supplemental Data | $94,362 | $98,243 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $58,404 | $125,402 | $676 | $24,358 |
| Beginning Cash Position | $125,402 | $616,696 | $24,358 | $93,875 |
| Effect Of Exchange Rate Changes | $2,976 | $18,790 | - | - |
| Changes In Cash | $-69,974 | $-510,084 | $-23,682 | $-69,517 |
| Net Issuance Payments Of Debt | $442,119 | $-137,819 | $40,970 | $50,000 |
| Net Long Term Debt Issuance | $442,119 | $-137,819 | $0 | $50,000 |
| Long Term Debt Payments | $-48,240 | $-211,672 | - | - |
| Long Term Debt Issuance | $490,359 | $73,853 | $0 | $50,000 |
| Net Business Purchase And Sale | $1,445 | $-150,000 | - | - |
| Sale Of Business | $1,445 | $0 | - | - |
| Purchase Of Business | $0 | $-150,000 | - | - |
| Net Intangibles Purchase And Sale | $0 | $-49,363 | - | - |
| Purchase Of Intangibles | $0 | $-49,363 | - | - |
| Net PPE Purchase And Sale | $-189,390 | $0 | - | - |
| Purchase Of PPE | $-189,390 | $0 | - | - |
| Change In Working Capital | $530,619 | $-421,588 | $7,724 | $-27,093 |
| Change In Other Working Capital | $-134,976 | $-80,623 | - | $-7,000 |
| Change In Payables And Accrued Expense | $387,726 | $-164,497 | $7,724 | $-21,064 |
| Change In Accrued Expense | $193,670 | $89,887 | - | - |
| Change In Interest Payable | $132,087 | $82,755 | - | - |
| Change In Payable | $194,056 | $-254,384 | $7,724 | $-21,064 |
| Change In Account Payable | $194,056 | $-254,384 | $7,724 | $-21,064 |
| Change In Prepaid Assets | $81,845 | $-119,093 | - | - |
| Change In Inventory | $106,435 | $-36,233 | - | - |
| Change In Receivables | $89,589 | $-21,142 | $0 | $971 |
| Changes In Account Receivables | $89,589 | $-21,142 | $0 | $971 |
| Other Non Cash Items | $897,041 | $543,371 | - | - |
| Asset Impairment Charge | $16,212,621 | $0 | - | - |
| Depreciation Amortization Depletion | $2,219,192 | $4,774 | $5,932 | $4,449 |
| Depreciation And Amortization | $2,219,192 | $4,774 | $5,932 | $4,449 |
| Gain Loss On Investment Securities | $2,870,396 | $2,501,853 | - | $165,000 |
| Net Income From Continuing Operations | $-23,054,017 | $-3,600,082 | $-117,308 | $-261,873 |
| Net Short Term Debt Issuance | - | $12,671 | $40,970 | $0 |
| Short Term Debt Payments | - | $-110 | $-700 | $0 |
| Short Term Debt Issuance | - | $12,781 | $41,670 | $0 |
| Unrealized Gain Loss On Investment Securities | - | $20,900 | $39,000 | $165,000 |
| Amortization Cash Flow | - | $5,932 | $5,932 | $4,449 |
| Amortization Of Intangibles | - | $5,932 | $5,932 | $4,449 |
Fetched: 2026-02-02